Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025 2025-12-11 21:00
HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach 2025-07-01 13:40
1